| B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer DP Hollern, N Xu, A Thennavan, C Glodowski, S Garcia-Recio, KR Mott, ... Cell 179 (5), 1191-1206. e21, 2019 | 337 | 2019 |
| STING agonist promotes CAR T cell trafficking and persistence in breast cancer N Xu, DC Palmer, AC Robeson, P Shou, H Bommiasamy, SJ Laurie, ... Journal of Experimental Medicine 218 (2), 2021 | 111 | 2021 |
| Tumor endothelial cells with distinct patterns of TGFβ-driven endothelial-to-mesenchymal transition L Xiao, DJ Kim, CL Davis, JV McCann, JM Dunleavey, AK Vanderlinden, ... Cancer research 75 (7), 1244-1254, 2015 | 71 | 2015 |
| Use of agonists to augment car t function in solid tumors J Serody, NP Restifo, XU Nuo US Patent App. 17/775,262, 2023 | | 2023 |
| Use of agonists to augment car t function in solid tumors NP Restifo, XU Nuo, J Serody | | 2021 |
| Optimizing and Understanding Checkpoint Inhibition Therapy and Chimeric Antigen Receptor Therapy Against Breast Cancer N Xu The University of North Carolina at Chapel Hill, 2020 | | 2020 |
| Licensing of CAR-T cell persistence and function by STING agonist in breast cancer N Xu, J Serody, N Restifo, D Palmer JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |
| Abstract GS1-05: Apobec3 induced mutagenesis sensitizes murine models of triple negative breast cancer to immunotherapy by activating B-cells and CD4+ T-cells DP Hollern, N Xu, KR Mott, X He, K Carey-Ewend, DS Marron, J Ford, ... Cancer Research 79 (4_Supplement), GS1-05-GS1-05, 2019 | | 2019 |
| Apobec3 induced mutagenesis sensitizes murine models of triple negative breast cancer to immunotherapy by activating B-cells and CD4+ T-cells DP Hollern, N Xu, KR Mott, X He, K Carey-Ewend, DS Marron, J Ford, ... CANCER RESEARCH 79 (4), 2019 | | 2019 |
Jonathan SerodyProfessor University of North Carolina at Chapel HillVerified email at med.unc.edu
